We analyzed LAPTM4B expression by in situ hybridization (ISH) in a NSCLC (n = 368) tissue microarray (TMA, 245 LUADs and 123 SCCs) derived from patients (Supplementary Table S1) who did not receive neoadjuvant treatment. Here, LAPTM4B is linked to non-small cell lung carcinoma.